Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib.

Konstam, M A

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. [electronic resource] - Circulation Nov 2001 - 2280-8 p. digital

Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

1524-4539

10.1161/hc4401.100078 doi


Aged
Alzheimer Disease--drug therapy
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Arthritis, Rheumatoid--drug therapy
Cardiovascular Diseases--epidemiology
Chronic Disease
Clinical Trials, Phase II as Topic--statistics & numerical data
Clinical Trials, Phase III as Topic--statistics & numerical data
Clinical Trials, Phase IV as Topic--statistics & numerical data
Comorbidity
Cyclooxygenase 1
Cyclooxygenase 2
Female
Humans
Isoenzymes--antagonists & inhibitors
Lactones--adverse effects
Low Back Pain--drug therapy
Male
Membrane Proteins
Middle Aged
Naproxen--adverse effects
Osteoarthritis--drug therapy
Proportional Hazards Models
Prostaglandin-Endoperoxide Synthases
Randomized Controlled Trials as Topic--statistics & numerical data
Risk
Sulfones
Thrombosis--epidemiology